Gonzalez-Rellan showed that semaglutide reversed MASH without the need for brain receptors controlling appetite, demonstrating that weight loss is not required for liver benefits
This information helps your provider determine whether symptoms are related to tirzepatide, dehydration, electrolyte imbalance, or an unrelated condition
While many symptoms improve over time, GI discomfort remains a leading reason for discontinuation, reinforcing the need for gradual dose titration, patient education, and a personalized approach when choosing a GLP-1 therapy
For example, thymosin alpha-1 may help some patients improve immune tolerance and surveillance, while LL-37 is sometimes explored for antimicrobial support but can be too activating for sensitive patients
Legitimate platforms are transparent about their pharmacy partners